National Institutes of Health
Construction Site
This article is work in progress and not yet part of the free encyclopedia IntactiWiki.
The U.S. National Institutes of Health (NIAID, FIC, NIHCD, NCI) funded the three major RCTs being used by the WHO to endorse circumcision as HIV prevention[1]. They continue to fund further "research" and promotion of circumcision as HIV prevention in Africa.
Contents
- 1 Three RCTs in Africa
- 2 Other Projects
- 3 Response from NIH
- 4 NICHD funded studies
- 5 Office of Inspector General (OIG) investigations of NIAID commercial partnerships
- 6 Office of Inspector General (OIG) investigations of NICHD commercial partnerships
- 7 Office of Inspector General (OIG) investigations of NIDA commercial partnerships
- 8 Office of Inspector General (OIG) investigation of the NIH's administration of the CTSA program
- 9 Weird Science
- 10 Continuing advocating for more circumcision
- 11 References
Three RCTs in Africa
The NIH funded the three major RCTs being used by the WHO to endorse circumcision as HIV prevention: One in Orange Farm, South Africa under the supervision of French circumcision proponent Bertran Auvert[2], one in Kenya under the supervision of North American circumcision proponent Robert C. Bailey and Stephen Moses[3], and one in Uganda under the supervision of North American circumcision proponent Ronald H. Gray[4].
Other Projects
The NIH fund other projects for the "research" and promotion of circumcision, such as the Center for Infectious Disease Research in Zambia, who in turn are collaborating with the University of Alabama, Birmingham to conduct a "study" an the "Feasibility, Acceptability, and Safety of Neonatal Male Circumcision in Lusaka, Zambia."
Response from NIH
NICHD funded studies
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is presently funding a five-year (2009-2013), $465,108 'study' entitled "HIV PREVALENCE, SEXUAL BEHAVIOR, AND ATTITUDES TOWARD CIRCUMCISION AMONG COLOMBIA" (sic) with the stated aim of investigating "individual, social, and structural influences on HIV risk and serostatus among men who have sex with men (MSM) in Bogota, Colombia...Moreover, it will evaluate the protection against HIV afforded by circumcision among MSM in Colombia"[5].
Office of Inspector General (OIG) investigations of NIAID commercial partnerships
On the 10 June 2011, the OIG published it's results from an audit of a contract between the National Institute of Allergy and Infectious Diseases (NIAID) and the University of California at San Francisco, which read in part:[6]
On the 21 September 2011, the OIG published it's results from two separate audits of NIAID contracts with Avecia Biologics Limited and NexBio, Inc. The reports read in part:[7][8]
On the 31 October 2011, the OIG published it's results from an audit of a contract between NIAID and the EMMES Corporation, which read in part:[9]
On the 14 September 2012, the OIG published it's results from two separate audits of NIAID contracts with PPD Development, LP. The reports read in part:[10][11]
Office of Inspector General (OIG) investigations of NICHD commercial partnerships
On the 17 October 2011, the OIG published it's results from an audit of a contract between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Westat, Inc., which read in part:[12]
Background information:[13]
Office of Inspector General (OIG) investigations of NIDA commercial partnerships
On the 26 October 2011, the OIG published it's results from an audit of a contract between the National Institute on Drug Abuse (NIDA) and Charles River Laboratories, Inc., which read in part:[14]
Office of Inspector General (OIG) investigation of the NIH's administration of the CTSA program
On the 20 December 2011, the OIG published a report critical of the NIH's administration of the Clinical and Translational Science Awards (CTSA) program.[15] The report read in part:
Weird Science
"NIH video reveals the science behind yoga"[16]
Continuing advocating for more circumcision
From a National HIV Vaccine Awareness Day statement dated 18 May 2011 by Anthony S. Fauci, M.D., Director of NIAID (emphasis added):[17]
References
- ↑ Template:Cite web
- ↑ Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med 2:e298. Full Text
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-56. Abstract
- ↑ Gray RH. Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369:557-66.
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web
- ↑ Template:Cite web